{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:03:00Z","timestamp":1787313780629,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cld.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T23:28:54Z","timestamp":1542410934000},"page":"55-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Alcohol Use Disorders in Alcoholic Liver Disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Jessica L.","family":"Mellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald Scott","family":"Winder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2018.09.004_bib1","series-title":"Diagnostic and statistical manual of mental disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.cld.2018.09.004_bib2","series-title":"The ASAM principles of addiction medicine","first-page":"1008","article-title":"Medical management techniques and collaborative care: integrating behavioral with pharmacologic interventions in addiction treatment","author":"Rosenthal","year":"2014"},{"issue":"10","key":"10.1016\/j.cld.2018.09.004_bib3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/lt.22370","article-title":"Substance use by liver transplant candidates: an anonymous urinalysis study","volume":"17","author":"Webzell","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/acer.13353","article-title":"Phosphatidylethanol detects moderate-to-heavy alcohol use in liver transplant recipients","volume":"41","author":"Fleming","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/acer.13556","article-title":"Detecting deception in our research participants: are your participants who you think they are?","volume":"42","author":"McCaul","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ajg.2018.6","article-title":"Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests","volume":"113","author":"Tapper","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.004_bib7","series-title":"The ASAM principles of addiction medicine","author":"Ries","year":"2014"},{"issue":"12","key":"10.1016\/j.cld.2018.09.004_bib8","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1360-0443.2005.01257.x","article-title":"Multi-level analysis of alcohol-related injury among emergency department patients: a cross-national study","volume":"100","author":"Cherpitel","year":"2005","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.cld.2018.09.004_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1360-0443.1995.tb03552.x","article-title":"The AUDIT questionnaire: choosing a cut-off score. Alcohol use disorder identification test","volume":"90","author":"Conigrave","year":"1995","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.cld.2018.09.004_bib10","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/acer.13276","article-title":"Follow-up of alcohol consumption after liver transplantation: interest of an addiction team?","volume":"41","author":"Donnadieu-Rigole","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.cld.2018.09.004_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2017.04.017","article-title":"Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease","volume":"67","author":"Westwood","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.004_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1530-0277.2006.00325.x","article-title":"Alcohol screening scores and risk of hospitalizations for GI conditions in men","volume":"31","author":"Au","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2015.11.006","article-title":"Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths","volume":"64","author":"Sheron","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"615","key":"10.1016\/j.cld.2018.09.004_bib15","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.3399\/bjgp13X673711","article-title":"Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS)","volume":"63","author":"Sheron","year":"2013","journal-title":"Br J Gen Pract"},{"issue":"6","key":"10.1016\/j.cld.2018.09.004_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1530-0277.2010.01170.x","article-title":"Alcohol biomarkers in applied settings: recent advances and future research opportunities","volume":"34","author":"Litten","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.cld.2018.09.004_bib17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/acer.12143","article-title":"BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin","volume":"37","author":"Fagan","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"12","key":"10.1016\/j.cld.2018.09.004_bib18","first-page":"1729","article-title":"Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease","volume":"25","author":"DiMartini","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.23596","article-title":"Assessing the drinking status of liver transplant patients with alcoholic liver disease","volume":"19","author":"Allen","year":"2013","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/alcalc\/agw069","article-title":"Relationship of abnormal chromatographic pattern for carbohydrate-deficient transferrin with severe liver disease","volume":"52","author":"Stewart","year":"2017","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.004_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cgh.2017.08.019","article-title":"Ethyl glucuronide in hair is an accurate biomarker of chronic excessive alcohol use in patients with alcoholic cirrhosis","volume":"16","author":"Verbeek","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2018.09.004_bib22","first-page":"1215","article-title":"Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study","volume":"26","author":"Anton","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1258\/acb.2011.011115","article-title":"Ethyl glucuronide","volume":"49","author":"Walsham","year":"2012","journal-title":"Ann Clin Biochem"},{"issue":"5","key":"10.1016\/j.cld.2018.09.004_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/anatox\/35.5.264","article-title":"Ethyl glucuronide, ethyl sulfate, and ethanol in urine after intensive exposure to high ethanol content mouthwash","volume":"35","author":"Reisfield","year":"2011","journal-title":"J\u00a0Analytical Toxicol"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/anatox\/35.2.85","article-title":"Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizer","volume":"35","author":"Reisfield","year":"2011","journal-title":"J\u00a0Analytical Toxicol"},{"issue":"10","key":"10.1016\/j.cld.2018.09.004_bib26","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1373\/clinchem.2007.089482","article-title":"Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption","volume":"53","author":"Helander","year":"2007","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.cld.2018.09.004_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jat\/29.5.270","article-title":"Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake","volume":"29","author":"Helander","year":"2005","journal-title":"J\u00a0Anal Toxicol"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1360-0443.2005.01245.x","article-title":"Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption","volume":"101","author":"Wurst","year":"2006","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.cld.2018.09.004_bib29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1530-0277.2011.01713.x","article-title":"Prolonged urinary detection times of EtG and EtS in patients with decreased renal function","volume":"36","author":"H\u00f8iseth","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"10.1016\/j.cld.2018.09.004_bib30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1530-0277.2012.01855.x","article-title":"Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients","volume":"37","author":"Stewart","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/alcalc\/ags109","article-title":"Hair ethyl glucuronide is highly sensitive and specific for detecting moderate-to-heavy drinking in patients with liver disease","volume":"48","author":"Stewart","year":"2013","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.004_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/liv.12243","article-title":"Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates","volume":"34","author":"Sterneck","year":"2014","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2018.09.004_bib34","first-page":"E14","article-title":"Higher levels of hair ethyl glucuronide in patients with decreased kidney function","volume":"37","author":"H\u00f8iseth","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/acer.13558","article-title":"Applications and challenges for the use of phosphatidylethanol testing in liver disease patients (mini review)","volume":"42","author":"Nguyen","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.cld.2018.09.004_bib36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1530-0277.2012.01768.x","article-title":"Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5\u00a0days","volume":"36","author":"Gnann","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2018.09.004_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2017.04.026","article-title":"Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test - C (AUDIT-C)","volume":"178","author":"Schr\u00f6ck","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1369-1600.2009.00185.x","article-title":"Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports","volume":"15","author":"Wurst","year":"2010","journal-title":"Addict Biol"},{"issue":"11","key":"10.1016\/j.cld.2018.09.004_bib39","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"Viel","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.cld.2018.09.004_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/alcalc\/agp039","article-title":"Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension","volume":"44","author":"Stewart","year":"2009","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"10.1016\/j.cld.2018.09.004_bib41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/acer.12442","article-title":"Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease","volume":"38","author":"Stewart","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2018.09.004_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yrtph.2018.01.029","article-title":"Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model","volume":"94","author":"Simon","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"10.1016\/j.cld.2018.09.004_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/tri.12949","article-title":"Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study","volume":"30","author":"Andresen-Streichert","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.cld.2018.09.004_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.alcohol.2017.08.009","article-title":"Evaluation of a novel method for the analysis of alcohol biomarkers: ethyl glucuronide, ethyl sulfate and phosphatidylethanol","volume":"67","author":"Nguyen","year":"2018","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jama.1995.03520280069043","article-title":"Preserving the physician-patient relationship in the era of managed care","volume":"273","author":"Emanuel","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib46","first-page":"139","article-title":"Relation between working alliance and outcome in psychotherapy: a meta-analysis","volume":"38","author":"Horvath","year":"1991","journal-title":"J\u00a0Couns Psychol"},{"issue":"4","key":"10.1016\/j.cld.2018.09.004_bib47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1037\/0022-006X.65.4.588","article-title":"The therapeutic alliance and its relationship to alcoholism treatment participation and outcome","volume":"65","author":"Connors","year":"1997","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsat.2006.04.001","article-title":"Therapeutic alliance and the relationship between motivation and treatment outcomes in patients with alcohol use disorder","volume":"31","author":"Ilgen","year":"2006","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.cld.2018.09.004_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2018.05.003","article-title":"Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis","volume":"91","author":"Mellinger","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"7","key":"10.1016\/j.cld.2018.09.004_bib50","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","author":"Lucey","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2018.09.004_bib51","first-page":"22A","article-title":"Drivers of short- and long-term mortality in severe alcoholic hepatitis: a complex relationship between alcohol relapse and early improvement in liver function","volume":"64","author":"Louvet","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2018.09.004_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajg.2015.204","article-title":"Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complication","volume":"110","author":"Dumortier","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2018.09.004_bib53","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jhep.2017.12.029","article-title":"Controlled attenuation parameter and alcoholic hepatic steatosis: diagnostic accuracy and role of alcohol detoxification","volume":"68","author":"Thiele","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.09.004_bib54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2017.10.019","article-title":"The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: an international study","volume":"68","author":"Alavi","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2018.09.004_bib55","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7326\/0003-4819-157-9-201211060-00544","article-title":"Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force","volume":"157","author":"Jonas","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2018.09.004_bib56","series-title":"Motivational interviewing","author":"Miller","year":"2012"},{"issue":"12","key":"10.1016\/j.cld.2018.09.004_bib57","article-title":"Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users","author":"Klimas","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of Psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"16","key":"10.1016\/j.cld.2018.09.004_bib59","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/archinte.159.16.1946","article-title":"A\u00a0randomized trial of integrated outpatient treatment for medically ill alcoholic men","volume":"159","author":"Willenbring","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2018.09.004_bib60","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/add.12875","article-title":"The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis","volume":"110","author":"Donoghue","year":"2015","journal-title":"Addiction"},{"issue":"18","key":"10.1016\/j.cld.2018.09.004_bib61","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"issue":"8491","key":"10.1016\/j.cld.2018.09.004_bib62","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(86)91196-7","article-title":"Naltrexone and hepatotoxicity","volume":"1","author":"Mitchell","year":"1986","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cld.2018.09.004_bib63","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archpsyc.1997.01830240090013","article-title":"The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group","volume":"54","author":"Croop","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.cld.2018.09.004_bib64","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"issue":"9603","key":"10.1016\/j.cld.2018.09.004_bib65","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2018.09.004_bib66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamainternmed.2013.11950","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"9370","key":"10.1016\/j.cld.2018.09.004_bib67","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.cld.2018.09.004_bib68","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.cld.2018.09.004_bib69","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.284.8.963","article-title":"Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial","volume":"284","author":"Johnson","year":"2000","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cld.2018.09.004_bib70","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:55:39Z","timestamp":1761069339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1089326118300801"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.09.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcohol Use Disorders in Alcoholic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}